[1] 李其泽,樊程,赵晓松,等. 婴儿胆汁淤积症的病因及临床指标分析[J]. 中华肝脏病杂志,2024,32(9):813-819. [2] El Raichani N, Thibault M, Alvarez F, et al. The effects of gestational age on neonatal cholestasis: a retrospective cohort study[J]. J Neonatal Perinatal Med, 2024, 17(1): 101-110. [3] Liu Z, Jin Y, Zhao Y, et al. Development and validation of a screening model for early diagnosis of biliary atresia in neonates with cholestasis[J]. Pediatr Surg Int, 2025, 42(1): 48. [4] Caramelo I, Coelho M, Rosado M, et al. Biomarkers of hypoxic-ischemic encephalopathy: a systematic review[J]. World J Pediatr, 2023, 19(6): 505-548. [5] Luo Y, Guo Y, Zhu Y, et al. How to differentiate pediatric enteroviral meningoencephalitis from scrub typhus meningoencephalitis: a single-center retrospective study from Yunnan Province, China[J]. Int J Infect Dis, 2026, 167: 108523. [6] 中华医学会儿科学分会感染学组,中华医学会儿科学分会消化学组,中华儿科杂志编辑委员会. 婴儿胆汁淤积症诊断与治疗专家共识[J]. 中华儿科杂志,2022,60(10):990-997. [7] Drozdowska-Szymczak A, Mazanowska N, Pomianek T, et al. Incidence and risk factors of cholestasis in newborns with hemolytic disease-a case-control study[J]. J Clin Med, 2024, 13(11): 3190. [8] Heinz N, Vittorio J. Treatment of cholestasis in infants and young children[J]. Curr Gastroenterol Rep, 2023, 25(11): 344-354. [9] Gürcan Kaya N, Öztürk H, Sarı S, et al. Neonatal cholestasis: exploring genetic causes and clinical outcomes[J]. J Paediatr Child Health, 2025, 61(7): 1049-1055. [10] Li J Q, Li Y, He R, et al. Biallelic pathogenic TULP3 variants presenting as neonatal cholestasis, liver fibrosis and neurological manifestations[J]. J Med Genet, 2025, 62(10): 631-640. [11] Tai C S, Ko S C, Lee C C, et al. A prediction model for genetic cholestatic disease in infancy using the machine learning approach[J]. J Pediatr Gastroenterol Nutr, 2025, 81(4): 933-942. [12] 姜霁洋,范振鑫,杨凡,等. 超重或肥胖儿童肠道菌群构成和毒力因子基因特征及其与肝脏代谢炎症相关分析[J]. 中华儿科杂志,2025,63(6):642-648. [13] Cimadamore E, Palazzo M, Fioroni M C, et al. Enteral nutrition in neonatal cholestasis: an up-to-date overview[J]. Nutrients, 2025, 17(11): 1794. [14] 张慧丽,周秀花,刘从丽,等. AST/ALT比值对妊娠期急性脂肪肝患者妊娠结局的影响:回顾性队列研究[J]. 中华围产医学杂志,2026,29(3):235-242. [15] Moin Z S, Evans H M, Buksh M J, et al. Cholestasis and hepatic dysfunction associated with parenteral nutrition in a tertiary neonatal intensive care unit (NICU): a retrospective cohort study[J]. Intest Fail, 2024, 11(4): 100045. [16] Lin Y, Zhang R, Ou W, et al. Retrospective assessment of the predictors of neonatal and infantile cholestasis with and without liver failure: an experience from Southeast China[J]. PeerJ, 2026, 14: e20800. [17] Fan X, Li X, Yu T, et al. Evaluation of alanine aminotransferase/aspartate aminotransferase ratio and high-density lipoprotein for predicting neonatal adverse outcomes associated with intrahepatic cholestasis of pregnancy[J]. PeerJ, 2024, 12: e17613. [18] Zhang Y, Luan H, Song P. Bilirubin metabolism and its application in disease prevention: mechanisms and research advances[J]. Inflamm Res, 2025, 74(1): 81. [19] 刘潇,蒙健林,王明刚,等. 解毒化瘀升散方抑制NLRP3信号通路缓解慢加急性肝衰竭大鼠炎症损伤的实验研究[J]. 中华肝脏病杂志,2024,32(4):354-362. [20] Fang L U, Guangyao C, Ju Y, et al. Association of high-sensitivity cardiac troponin I, platelet counts, and total bilirubin/albumin ratio with the severity of neonatal hyperbilirubinemia[J]. Physiol Res, 2025, 74(4): 571-576. |